{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:10:19Z","timestamp":1791205819300,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,11,28]],"date-time":"2007-11-28T00:00:00Z","timestamp":1196208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00392-007-0617-6","type":"journal-article","created":{"date-parts":[[2007,11,28]],"date-time":"2007-11-28T11:54:42Z","timestamp":1196250882000},"page":"244-252","source":"Crossref","is-referenced-by-count":39,"title":["Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy"],"prefix":"10.1007","volume":"97","author":[{"given":"F.","family":"Peters-Klimm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"M\u00fcller-Tasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schellberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Remppis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Holzapfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"J\u00fcnger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Szecsenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,28]]},"reference":[{"key":"617_CR1","doi-asserted-by":"crossref","unstructured":"A fifth amendment for the declaration of Helsinki (2000) Lancet 356(9236): 1123","DOI":"10.1016\/S0140-6736(00)02746-X"},{"issue":"3","key":"617_CR2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","volume":"355","author":"RS Bhatia","year":"2006","unstructured":"Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355(3):260\u2013269","journal-title":"N Engl J Med"},{"key":"617_CR3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2296-7-40","volume":"7","author":"FJ Bongers","year":"2006","unstructured":"Bongers FJ, Schellevis FG, Bakx C, van den Bosch WJ, van der Zee J (2006) Treatment of heart failure in Dutch general practice. BMC Fam Pract 7:40","journal-title":"BMC Fam Pract"},{"issue":"6","key":"617_CR4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/heart.89.6.605","volume":"89","author":"ML Bouvy","year":"2003","unstructured":"Bouvy ML, Heerdink ER, Leufkens HG, Hoes AW (2003) Predicting mortality in patients with heart failure: a pragmatic approach. Heart 89(6):605\u2013609","journal-title":"Heart"},{"issue":"9346","key":"617_CR5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0140-6736(02)11601-1","volume":"360","author":"JG Cleland","year":"2002","unstructured":"Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, et al. (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360(9346): 1631\u20131639","journal-title":"Lancet"},{"issue":"5","key":"617_CR6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","volume":"24","author":"JG Cleland","year":"2003","unstructured":"Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. (2003) The EuroHeart Failure survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24(5):442\u2013463","journal-title":"Eur Heart J"},{"issue":"8","key":"617_CR7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00392-005-0245-y","volume":"94","author":"K Drechsler","year":"2005","unstructured":"Drechsler K, Dietz R, Klein H, Wollert KC, Storp D, Molling J, et al. (2005) Euro heart failure survey. Medical treatment not in line with current guidelines. Z Kardiol 94(8):510\u2013515","journal-title":"Z Kardiol"},{"issue":"7321","key":"617_CR8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/bmj.323.7321.1100","volume":"323","author":"AC Freeman","year":"2001","unstructured":"Freeman AC, Sweeney K (2001) Why general practitioners do not implement evidence: qualitative study. BMJ 323(7321):1100\u20131102","journal-title":"BMJ"},{"issue":"2","key":"617_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00392-006-0334-6","volume":"95","author":"EB Friedrich","year":"2006","unstructured":"Friedrich EB, Teo KK, Bohm M (2006) ACE inhibition in secondary prevention: are the results controversial? Clin Res Cardiol 95(2):61\u201367","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"617_CR10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00392-005-0268-4","volume":"94","author":"UC Hoppe","year":"2005","unstructured":"Hoppe UC, Bohm M, Dietz R, Hanrath P, Kroemer HK, Osterspey A, et al. (2005) Guidelines for therapy of chronic heart failure. Z Kardiol 94(8):488\u2013509","journal-title":"Z Kardiol"},{"issue":"3","key":"617_CR11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s003920170187","volume":"90","author":"UC Hoppe","year":"2001","unstructured":"Hoppe UC, Erdmann E (2001) Guidelines for the treatment of chronic heart failure. Issued by the Executive Committee of the German Society of Cardiology-Heart and Circulation Research, compiled on behalf of the Commission of Clinical Cardiology in cooperation with Pharmaceutic Commission of the German Physicians\u2019 Association. Z Kardiol 90(3):218\u2013237","journal-title":"Z Kardiol"},{"issue":"3","key":"617_CR12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/heart.87.3.235","volume":"87","author":"J Juenger","year":"2002","unstructured":"Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, et al. (2002) Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 87(3):235\u2013241","journal-title":"Heart"},{"issue":"3","key":"617_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2796.2003.01282.x","volume":"255","author":"DG Julian","year":"2004","unstructured":"Julian DG (2004) Translation of clinical trials into clinical practice. J Intern Med 255(3):309\u2013316","journal-title":"J Intern Med"},{"issue":"6","key":"617_CR14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1388-9842(02)00119-8","volume":"4","author":"K Khunti","year":"2002","unstructured":"Khunti K, Hearnshaw H, Baker R, Grimshaw G (2002) Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 4(6):771\u2013777","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"617_CR15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","volume":"24","author":"M Komajda","year":"2003","unstructured":"Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, et al. (2003) The EuroHeart Failure Survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24(5):464\u2013474","journal-title":"Eur Heart J"},{"issue":"16","key":"617_CR16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/eurheartj\/ehi251","volume":"26","author":"M Komajda","year":"2005","unstructured":"Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, et al. (2005) Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 26(16):1653\u20131659","journal-title":"Eur Heart J"},{"issue":"3","key":"617_CR17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejheart.2006.07.007","volume":"9","author":"M Lainscak","year":"2007","unstructured":"Lainscak M, Cleland JG, Lenzen MJ, Follath F, Komajda M, Swedberg K (2007) International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey. Eur J Heart Fail 9(3):292\u2013299","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"617_CR18","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehi499","volume":"26","author":"MJ Lenzen","year":"2005","unstructured":"Lenzen MJ, Boersma E, Scholte op Reimer WJM, Balk AHMM, Komajda M, Swedberg K, et al. (2005) Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 26(24):2706\u20132713","journal-title":"Eur Heart J"},{"issue":"5","key":"617_CR19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/clpt.1990.186","volume":"48","author":"DR Luke","year":"1990","unstructured":"Luke DR, Halstenson CE, Opsahl JA, Matzke GR (1990) Validity of creatinine clearance estimates in the assessment of renal function. Clin Pharmacol Ther 48(5):503\u2013508","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"617_CR20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ejheart.2004.03.011","volume":"6","author":"J Muntwyler","year":"2004","unstructured":"Muntwyler J, Cohen-Solal A, Freemantle N, Eastaugh J, Cleland JG, Follath F (2004) Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe. Eur J Heart Fail 6(5):663\u2013668","journal-title":"Eur J Heart Fail"},{"issue":"3 Suppl","key":"617_CR21","first-page":"6","volume":"23","author":"JB O\u2019Connell","year":"2000","unstructured":"O\u2019Connell JB (2000) The economic burden of heart failure. Clin Cardiol 23(3 Suppl):6\u201310","journal-title":"Clin Cardiol"},{"issue":"3","key":"617_CR22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355(3):251\u2013259","journal-title":"N Engl J Med"},{"issue":"10","key":"617_CR23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709\u2013717","journal-title":"N Engl J Med"},{"issue":"3","key":"617_CR24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00392-006-0348-0","volume":"95","author":"R Reibis","year":"2006","unstructured":"Reibis R, Dovifat C, Dissmann R, Ehrlich B, Schulz S, Stolze K, et al. (2006) Implementation of evidence-based therapy in patients with systolic heart failure from 1998\u20132000. Clin Res Cardiol 95(3):154\u2013161","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"617_CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1388-9842(01)00231-8","volume":"4","author":"WJ Remme","year":"2002","unstructured":"Remme WJ, Swedberg K (2002) Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 4(1):11\u201322","journal-title":"Eur J Heart Fail"},{"issue":"5402","key":"617_CR26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/bmj.2.5402.177","volume":"2","author":"PP Rickham","year":"1964","unstructured":"Rickham PP (1964) Human experimentation. Code of ethics of the world medical association. Declaration of helsinki. Br Med J 2(5402):177","journal-title":"Br Med J"},{"issue":"3","key":"617_CR27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1388-9842(03)00050-3","volume":"5","author":"FH Rutten","year":"2003","unstructured":"Rutten FH, Grobbee DE, Hoes AW (2003) Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 5(3):337\u2013344","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"617_CR28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0735-1097(03)00262-6","volume":"41","author":"PG Shekelle","year":"2003","unstructured":"Shekelle PG, Rich MW, Morton SC, Atkinson CS, Tu W, Maglione M, et al. (2003) Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol 41(9):1529\u20131538","journal-title":"J Am Coll Cardiol"},{"issue":"7557","key":"617_CR29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","volume":"333","author":"SH Simpson","year":"2006","unstructured":"Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. (2006) A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 333(7557):15","journal-title":"BMJ"},{"issue":"3","key":"617_CR30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1388-9842(00)00141-0","volume":"3","author":"S Stewart","year":"2001","unstructured":"Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ (2001) More \u2018malignant\u2019 than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 3(3):315\u2013322","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"617_CR31","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","volume":"26","author":"K Swedberg","year":"2005","unstructured":"Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 26(11):1115\u20131140","journal-title":"Eur Heart J"},{"issue":"3","key":"617_CR32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"The Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","unstructured":"The Heart Outcomes Prevention Evaluation Study Investigators (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342(3):145\u2013153","journal-title":"N Engl J Med"},{"issue":"3","key":"617_CR33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0735-1097(02)01970-8","volume":"40","author":"J Wikstrand","year":"2002","unstructured":"Wikstrand J, Hjalmarson A, Waagstein F, Fagerberg B, Goldstein S, Kjekshus J, et al. (2002) Dose of metoprolol CR\/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR\/XL randomized intervention trial in chronic heart failure (MERIT-HF). J Am Coll Cardiol 40(3):491\u2013498","journal-title":"J Am Coll Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-007-0617-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-007-0617-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-007-0617-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:21:52Z","timestamp":1559060512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-007-0617-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,28]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1007\/s00392-007-0617-6","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,28]]}}}